Spring til hovednavigation Spring til søgning Spring til hovedindhold

Investigating Potential Adverse Drug Reactions of Lisdexamfetamine Using Sequence Symmetry Analysis

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

7 Downloads (Pure)

Abstract

The prevalence of ADHD is increasing rapidly, and lisdexamfetamine is increasingly popular, but few studies investigate its safety. We performed a sequence symmetry analysis (SSA) using Danish register data to identify potential ADRs associated with lisdexamfetamine in 2013-2023. Outcomes were incident prescriptions or incident discharge diagnoses. We calculated trend-adjusted sequence ratios (SR) with 95% confidence intervals (CI). We additionally performed two comparator SSAs for the same outcomes following incident use of stimulants (methylphenidate and dexamfetamine) or non-stimulants (guanfacine and atomoxetine). This study is reported according to RECORD-PE guidelines. We included 48 740 incident lisdexamfetamine users with a median age of 24 years (IQR 16-35). SRs were calculated for 1426 exposure-diagnosis and 1337 exposure-prescription pairs. The 50 highest SRs from each category were evaluated. Among these, 28 exposure-outcome combinations had a 95% CI lower bound above 1. Of the 100 outcomes, 33 were considered known ADRs, while 60 were previously unknown. Two outcomes indicating increased urinary symptoms were identified ('hematuria', SR: 1.88 [95% CI: 1.25; 2.85] and 'other urinary symptoms', SR: 1.63 [1.20; 2.23]). We also identified serious gastrointestinal outcomes as a potential safety alert. Further investigation into these symptoms as potential ADRs is warranted.
OriginalsprogEngelsk
Artikelnummere70316
TidsskriftBasic & clinical pharmacology & toxicology
Vol/bind139
Udgave nummer5
Antal sider10
ISSN1742-7835
DOI
StatusUdgivet - 2026

Citationsformater